• Markets
  • icon
  • Companies
LBT · ASX

LBT Innovations Limited (ASX:LBT)

AU$0.017

 0.0 (0.0%)
ASX:Live
21/05/2024 01:19:53 PM
HALO Ords GROWTH AUS All-Companies
Consensus Score
/10
Recommend
Target Price
Deviation
Unlock Full Consensus Insights

LBT Overview

LBT Health Scores

Short Term

Mean Revision

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Very Strong

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About LBT

Telephone

N/A

Address

Description

LBT Innovations Ltd. engages in the business of researching, developing, and commercializing innovative technologies for healthcare and laboratory supply markets. It operates through the following geographical regions: Australia, Switzerland, the United States, Sweden, the United Kingdom, and Germany. The company was founded by Lusia Halina Guthrie, Douglas Peter LeMessurier, and Paul Andrew Mariani in 2004 and is headquartered in Adelaide, Australia.

LBT Price Chart

Key Stats

Market Cap

AU$21.45M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.0 - 0.04

Trade Value (12mth)

AU$9,493.00

1 week

0%

1 month

-15%

YTD

70%

1 year

-36.09%

All time high

0.7595000267028809

Key Fundamentals

EPS 3 yr Growth

100.000%

EBITDA Margin

-180.30%

Operating Cashflow

-$1m

Free Cash Flow Return

-10.50%

ROIC

-169.70%

Interest Coverage

-8.20

Quick Ratio

0.80

Other Data

Shares on Issue (Fully Dilluted)

572m

HALO Sector

Next Company Report Date

29-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

LBT Announcements

Latest Announcements

Date Announcements

09 May 24

Application for quotation of securities - LBT

×

Application for quotation of securities - LBT

30 April 24

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

29 April 24

APAS PHARMAQC SALE TO NOVACINA

×

APAS PHARMAQC SALE TO NOVACINA

18 April 24

Application for quotation of securities - LBT

×

Application for quotation of securities - LBT

05 April 24

Application for quotation of securities - LBT

×

Application for quotation of securities - LBT

26 March 24

Application for quotation of securities - LBT

×

Application for quotation of securities - LBT

26 March 24

Change in substantial holding

×

Change in substantial holding

18 March 24

Application for quotation of securities - LBT

×

Application for quotation of securities - LBT

13 March 24

APAS PharmaQC Commercially Ready - Performance Finalised

×

APAS PharmaQC Commercially Ready - Performance Finalised

13 March 24

Application for quotation of securities - LBT

×

Application for quotation of securities - LBT

26 February 24

Quarterly Investor Call

×

Quarterly Investor Call

23 February 24

Half Yearly Report and Accounts

×

Half Yearly Report and Accounts

22 February 24

APAS PharmaQC Demonstrated at AstraZeneca UK Site

×

APAS PharmaQC Demonstrated at AstraZeneca UK Site

22 February 24

Delivery Completes First Sale of APAS PharmaQC

×

Delivery Completes First Sale of APAS PharmaQC

16 February 24

Notification regarding unquoted securities - LBT

×

Notification regarding unquoted securities - LBT

12 February 24

Proposed issue of securities - LBT

×

Proposed issue of securities - LBT

07 February 24

APAS PharmaQC BioPhorum Presentation to Industry Leaders

×

APAS PharmaQC BioPhorum Presentation to Industry Leaders

05 February 24

Company Presentation

×

Company Presentation

05 February 24

Application for quotation of securities - LBT

×

Application for quotation of securities - LBT

22 January 24

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

17 January 24

Application for quotation of securities - LBT

×

Application for quotation of securities - LBT

10 January 24

Notification of cessation of securities - LBT

×

Notification of cessation of securities - LBT

22 December 23

Notice of initial substantial holder

×

Notice of initial substantial holder

22 December 23

Notice under Section 708A - Cleansing Notice

×

Notice under Section 708A - Cleansing Notice

22 December 23

Change of Director's Interest Notice - R Wilson

×

Change of Director's Interest Notice - R Wilson

LBT Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.03 -0.02 -0.05 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.03 -0.02 -0.05 Lock Lock Lock
     Growth % Lock Lock Lock Lock -5.9 13.8 -119.3 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.01 -0.01 -0.01 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.01 -0.02 -0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock 16.3 -5.4 -20.8 Lock Lock Lock
     Yield % Lock Lock Lock Lock -12.8 -21.1 -14.2 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.09 0.07 -0.00 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.03 0.02 -0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock 8.5 -53.4 -101.3 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 287 305 471 Lock Lock Lock
Basic m Lock Lock Lock Lock 287 305 471 Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 1 2 2 Lock Lock Lock
     Growth % Lock Lock Lock Lock -3.4 89.5 0.2 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 1 2 2 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock -6 -6 -6 Lock Lock Lock
     Growth % Lock Lock Lock Lock -9.2 -10.4 10.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock -505.2 -294.3 -263.8 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 605 394 364 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -4 -5 -4 Lock Lock Lock
     Growth % Lock Lock Lock Lock -14.1 -30.6 22.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock -338.9 -233.5 -180.3 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 2 3 3 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -6 -8 -7 Lock Lock Lock
     Growth % Lock Lock Lock Lock -7.6 -27.3 9.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock -552.5 -371.2 -334.9 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -6 -8 -21 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -2 -2 2 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -7 -7 -23 Lock Lock Lock
     Growth % Lock Lock Lock Lock -28.8 8.5 -239.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock -646.5 -312.1 -1,056.5 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -3 -5 -1 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 1 1 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -2 -1 0 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 7 -1 1 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -3 -5 -1 Lock Lock Lock
     Growth % Lock Lock Lock Lock -47.2 -80.3 72.0 Lock Lock Lock
     Margin % Lock Lock Lock Lock -2.5 -2.4 -0.7 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 10 3 2 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 36 32 7 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 4 3 2 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -5 1 1 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 11 10 7 Lock Lock Lock
Equity $m Lock Lock Lock Lock 25 21 0 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 29 24 2 Lock Lock Lock
     Growth % Lock Lock Lock Lock 5.8 -14.5 -91.5 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -20.3 -21.1 -305.6 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -29.2 -31.1 21,451.4 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -21.5 -28.5 -49.4 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -26.1 -25.0 -169.7 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -9.6 -18.6 -10.5 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock -32.8 -47.8 -8.2 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 1.2 -0.3 -0.4 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -19.1 7.0 -1,301.9 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 4.5 2.4 1.2 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 4.5 2.1 0.8 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 83.1 39.9 41.7 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -103.4 -173.3 -33.4 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 0.8 0.8 0.9 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock N/A 17.1 6.3 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.1 0.5 3.3 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 125.4 38.7 31.9 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.0 0.1 0.3 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.0 0.1 0.3 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -515.3 -385.6 -979.5 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -16.2 -26.0 -283.4 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -20.3 -21.1 -305.6 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.4 1.5 -70.2 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -29.2 -31.1 21,451.4 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -29.2 -31.1 21,451.4 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock N/A 21.3 58.1 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 453.2 442.7 388.7 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 453.2 464.0 446.8 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 56.0 43.4 33.2 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 397.2 420.6 413.7 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

LBT Shortsell

Frequently Asked Questions

The current share price of LBT Innovations Limited (LBT:ASX) is AU$0.017.
The 52-week high share price for LBT Innovations Limited (LBT:ASX) is AU$0.04.
The 52-week low share price for LBT Innovations Limited (LBT:ASX)? is AU$0.00.
LBT Innovations Limited (LBT:ASX) does not pay a dividend.
LBT Innovations Limited (LBT:ASX) does not pay a dividend.
LBT Innovations Limited (LBT:ASX) has a franking level of 0.0%.
LBT Innovations Limited (LBT:ASX) is classified in the Healthcare.
The current P/E ratio for LBT Innovations Limited (LBT:ASX) is .